Copyright © 2008 Sophie Collot-Teixeira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. T. Doi, K.-I. Higashino, Y. Kurihara, et al., “Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors,” The Journal of Biological Chemistry, vol. 268, no. 3, pp. 2126–2133, 1993.
2. T. Mazzone, “Scavenger receptors in atherosclerosis: new answers, new questions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 12, pp. 2506–2508, 2000.
3. V. V. Kunjathoor, M. Febbraio, E. A. Podrez, et al., “Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages,” The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49982–49988, 2002. View at Publisher · View at Google Scholar · View at PubMed
4. M. Febbraio, E. A. Podrez, J. D. Smith, et al., “Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice,” The Journal of Clinical Investigation, vol. 105, no. 8, pp. 1049–1056, 2000. View at Publisher · View at Google Scholar · View at PubMed
5. E. Guy, S. Kuchibhotla, R. Silverstein, and M. Febbraio, “Continued inhibition of atherosclerotic lesion development in long term Western diet fed ${\text{CD36}}^{\circ }$/${\text{apoE}}^{\circ }$ mice,” Atherosclerosis, vol. 192, no. 1, pp. 123–130, 2007. View at Publisher · View at Google Scholar · View at PubMed
6. K. J. Moore, V. V. Kunjathoor, S. L. Koehn, et al., “Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice,” The Journal of Clinical Investigation, vol. 115, no. 8, pp. 2192–2201, 2005. View at Publisher · View at Google Scholar · View at PubMed
7. S. Collot-Teixeira, J. Martin, C. McDermott-Roe, R. Poston, and J. L. McGregor, “CD36 and macrophages in atherosclerosis,” Cardiovascular Research, vol. 75, no. 3, pp. 468–477, 2007. View at Publisher · View at Google Scholar · View at PubMed
8. M. Febbraio and R. L. Silverstein, “CD36: implications in cardiovascular disease,” The International Journal of Biochemistry & Cell Biology, vol. 39, no. 11, pp. 2012–2030, 2007. View at Publisher · View at Google Scholar · View at PubMed
9. S. M. Schwartz, Z. S. Galis, M. E. Rosenfeld, and E. Falk, “Plaque rupture in humans and mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 705–713, 2007. View at Publisher · View at Google Scholar · View at PubMed
10. Y. Nakagawa-Toyama, S. Yamashita, J.-I. Miyagawa, et al., “Localization of CD36 and scavenger receptor class A in human coronary arteries—a possible difference in the contribution of both receptors to plaque formation,” Atherosclerosis, vol. 156, no. 2, pp. 297–305, 2001. View at Publisher · View at Google Scholar
11. C. Londos, D. L. Brasaemle, C. J. Schultz, J. P. Segrest, and A. R. Kimmel, “Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells,” Seminars in Cell & Developmental Biology, vol. 10, no. 1, pp. 51–58, 1999. View at Publisher · View at Google Scholar · View at PubMed
12. G. Larigauderie, C. Furman, M. Jaye, et al., “Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 504–510, 2004. View at Publisher · View at Google Scholar · View at PubMed
13. K. Nuotio, P. M. Isoviita, J. Saksi, et al., “Adipophilin expression is increased in symptomatic carotid atherosclerosis: correlation with red blood cells and cholesterol crystals,” Stroke, vol. 38, no. 6, pp. 1791–1798, 2007. View at Publisher · View at Google Scholar · View at PubMed
14. X. Wang, T. J. Reape, X. Li, et al., “Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions,” FEBS Letters, vol. 462, no. 1-2, pp. 145–150, 1999. View at Publisher · View at Google Scholar
15. P. J. Barter and K.-A. Rye, “The rationale for using apoA-I as a clinical marker of cardiovascular risk,” Journal of Internal Medicine, vol. 259, no. 5, pp. 447–454, 2006. View at Publisher · View at Google Scholar · View at PubMed
16. H. C. Stary, A. B. Chandler, R. E. Dinsmore, et al., “A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association,” Circulation, vol. 92, no. 5, pp. 1355–1374, 1995.
17. R. R. Johnson-Tidey, J. L. McGregor, P. R. Taylor, and R. N. Poston, “Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1,” The American Journal of Pathology, vol. 144, no. 5, pp. 952–961, 1994.
18. R. N. Poston, D. O. Haskard, J. R. Coucher, N. P. Gall, and R. R. Johnson-Tidey, “Expression of intercellular adhesion molecule-1 in atherosclerotic plaques,” The American Journal of Pathology, vol. 140, no. 3, pp. 665–673, 1992.
19. C. Albrecht, S. Soumian, J. S. Amey, et al., “ABCA1 expression in carotid atherosclerotic plaques,” Stroke, vol. 35, no. 12, pp. 2801–2806, 2004. View at Publisher · View at Google Scholar · View at PubMed
20. A. Nakata, Y. Nakagawa, M. Nishida, et al., “CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 5, pp. 1333–1339, 1999.